Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4435-4441

  Sheu, John R ^a   Chang, Chang C ^a   Tsai, Mei L ^a   Chung, Woei J ^a  

^a Gwo Chyang GMP Pharmaceutical Co Ltd   (Taiwan)

Author keywords

Angiogenesis; Endothelial cells; Shark cartilage; Tumor cell growth; U 995

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN; COLLAGENASE; TUMOR NECROSIS FACTOR ALPHA; U 995; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG PURIFICATION; EMBRYO; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; METASTASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ALLANTOIS; ANIMALS; ANTINEOPLASTIC AGENTS; CARTILAGE; CELL DIVISION; CELL MOVEMENT; CHICK EMBRYO; CHORION; COLLAGENASES; ENDOTHELIUM, VASCULAR; HUMANS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PROTEINS; SARCOMA 180; SHARKS; THYMIDINE; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0032423653     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. D'Amore PA and Thompson RW: Mechanisms of angiogenesis. Ann Rev Physiol 49: 453-464, 1987.
2. Blood CH and Zetler BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118, 1990.
3. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 3: 65-71, 1992.
4. Weinstat-Saslow D and Steeg PS: Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J 8: 401-407, 1994.
5. Schor AM and Schor SL: Tumor angiogenesis. J Pathol 14: 385-413, 1983.
6. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987.
7. Fan TP, Jaggar R and Bicknell R: Controlling the vascular: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trend Pharmacol Sci 16: 57-66, 1995.
8. Lee A and Langer R: Shark cartilage contains inhibitors of tumor angiogenesis. Science 221: 1185-1187, 1983.
9. Oikawa T, Ashino-Fuse H, Shimamura M, Koide U and Iwaguchi T: A novel angiogenic (I) derived from Japanese shark cartilage. Cancer Lett 5: 181-186, 1990.
10. Jaffe EA, Hoyer LW and Nachman RL: Synthesis of antihemophilic factor antigen by cultured endothelial cells. J Clin Invest 52: 2757-2764, 1973.
11. Leavesley DI, Ferguson GD, Wayner EA and Cheresh DA: Requirement of the integrin 63 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 117: 1101-1107, 1992.
12. VanWart HE and Steinbrink DR: A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal Biochem 113: 356-365, 1981.
13. Masuda E and Maeda H: Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative I. MethA tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS. Cancer Immunol Immunother 40: 329-338, 1995.
14. Roughley PJ, Murphy G and Barrett AJ: Proteinase inhibitors of bovine nasal cartilage. Biochem J 169: 721-724, 1978.
15. Murray JB, Allison K, Sudhalter J and Langer R: Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor. J Biol Chem 267: 4145-4159, 1986.
16. Langer R and Murray J: Angiogenesis inhibitors and their delivery systems. Appl Biochem Biotechnol 8: 9-24, 1983.
17. Thorgiersson UP, Liotta LA, Kalebic T, Margulies IM, Thomas K, Rios-Candelore M and Russo RJ: Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion In vitro. J Natl Cancer Inst 69: 1049-1054, 1982.
18. Taylor S and Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297: 307-312, 1982.
19. Danesi R, Del BS, Soldani P, Campagni A, La RR, Myers CE, Paparelli A and Del TM: Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer 68: 932-938, 1993.
20. Yanai S, Okada H, Saito K, Kuge Y, Misaki M, Ogawa Y and Toguchi H: Antitumor effect of arterial administration of a medium-chain triglyceride solution of an angiogenesis inhibitor, TNP-470, in rabbits bearing VX-2 carcinoma. Pharm Res 12: 653-657, 1995.